Corvus Pharmaceuticals, Inc.

Q2 2026 13F Holders

Symbol
CRVS
CUSIP
221015100
Type
Equity
Class
COM
Num filers
174
Total reported value, excl. options
$1.06B
Manager Report Date Value ($000) Shares